Higher circulating lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. Olpasiran is a small interfering RNA molecule that reduces LP(a). New research findings are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback